DI PERRI, Giovanni

DI PERRI, Giovanni  

SCIENZE MEDICHE  

Mostra records
Risultati 1 - 20 di 615 (tempo di esecuzione: 0.006 secondi).
Titolo Data di pubblicazione Autore(i) File
2019 novel coronavirus (2019-nCoV) outbreak: A new challenge 2020 Lupia T.; Scabini S.; Mornese Pinna S.; Di Perri G.; De Rosa F.G.; Corcione S.
A 30-years Review on Pharmacokinetics of Antibiotics: Is the Right Time for Pharmacogenetics? 2014 Baietto, L; Corcione, S; Pacini, G; Di Perri, G; D'Avolio, A; De Rosa, FG
A case of dengue type 3 virus infection imported from Africa to Italy, October 2009 2010 Nisii C; Carletti F; Castilletti C; Bordi L; Meschi S; Selleri M; Chiappini R; Travaglini D; Antonini M; Castorina S; Lauria FN; Narciso P; Gentile M; Martini L; Di Perri G; Audagnotto S; Biselli R; Lastilla M; Di Caro A; Capobianchi M; Ippolito G.
A concentration-dependent pharmacokinetic interaction with telaprevir increases ribavirin concentrations and leads to higher haemoglobin drop 2014 A. De Nicolò; A. Ciancio; L. Boglione; A. Mohamed Abdi; A. Smedile; G.P. Caviglia; G. DI Perri; M. Rizzetto; A. D'Avolio
A new HPLC method to measure plasma levels of enfuvirtide (ENF or T-20) 2004 D'Avolio A.; Sciandra M.; Bonora S.; Ibanez A.; Marucco D.; Di Perri G.
A new validated Solid Phase Extraction (SPE)-HPLC method to measure plasma concentrations of tenofovir 2004 D'Avolio A.; Sciandra M.; Bonora S.; Boffito M.; Canta F.; De Requena D.; Di Perri G.
A population pharmacokinetic model confirms an association between a pregnane-X-receptor (PXR) polymorphism and unboosted atazanavir clearance 2009 Schipani A; Siccardi M; D'Avolio A; Baietto L; Calcagno A; Tettoni C; Bonora S; Davis G; Khoo S; Back DJ; Di Perri G; Owen A
A Population Pharmacokinetic Model Illustrates an Association Between a Pregnane-X-Receptor (PXR) Polymorphism and Boosted Atazanavir Clearance 2010 Schipani A; Siccardi M; Boffito M; D’Avolio A; Bonora S; Davies G; Khoo S; Back D; Di Perri G; Owen A
A review of the safety and tolerability profile of the next-generation NNRTI etravirine. 2010 Grinsztejn B; Di Perri G; Towner W; Woodfall B; De Smedt G; Peeters M.
A short course of pegylated interferon-alpha in acute HCV hepatitis 2007 CALLERI G; CARITI G; GAIOTTINO F; DE ROSA FG; BARGIACCHI O; AUDAGNOTTO S; QUAGLIA S; DE BLASI T; ROMANO P; TRAVERSO A; LEO G; CARBONE R; DEL MASTRO B; TINELLI M; CARAMELLO P; DI PERRI G
A(H1N1)pdm09 hemagglutinin D222G and D222N variants are frequently harbored by patients requiring extracorporeal membrane oxygenation and advanced respiratory assistance for severe A(H1N1)pdm09 infection 2013 Ruggiero T;De Rosa F;Cerutti F;Pagani N;Allice T;Stella ML;Milia MG;Calcagno A;Burdino E;Gregori G;Urbino R;Di Perri G;Ranieri MV;Ghisetti V
ABCB1 3435C>T e CYP2B6 516G>T possono predire le concentrazioni plasmatiche ottimali di Nevirapina 2009 Antonio D'Avolio; Marco Siccardi; Deborah Gatti; Lorena Baietto; Francesca Romana Stefani; Marco Simiele; Mauro Sciandra; Stefano Bonora; Giovanni Di Perri
ABCB11 and ABCB1 gene polymorphisms impact on telaprevir pharmacokinetic at one month of therapy 2015 Cusato, Jessica; Allegra, Sarah; DE NICOLO', Amedeo; Boglione, Lucio; Fatiguso, Giovanna; Giuseppe, Cariti; Ciancio, Alessia; Smedile, Antonina; Strona, Silvia; Giulia, Troshina; Rizzetto, Mario; DI PERRI, Giovanni; D'Avolio, Antonio
Acute hepatitis C: dosage and compliance 2006 DE ROSA F; CARITI G; DI PERRI G
Aetiology of pneumonia following isolated closed head injury. 1997 CAZZADORI A ;DI PERRI G ;VENTO S ;BONORA S ;FENDT D ;ROSSI M ;LANZAFAME M ;MIRANDOLA F ;CONCIA E
Ageing with HIV: a multidisciplinary review 2015 Calcagno, A; Nozza, S; Mussi, C; Celesia, BM; Carli, F; Piconi, S; De Socio, GV; Cattelan, AM; Orofino, G; Ripamonti, D; Riva, A; Di Perri, G
AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals. 2003 NASTI G; TALAMINI R; ANTINORI A; MARTELLOTTA F; JACCHETTI G; CHIODO F; BALLARDINI G; STOPPINI L; G. DI PERRI; MENA M; TAVIO M; VACCHER E; D'ARMINIO; MONFORTE A; TIRELLI U
Alpha 1-acid glycoprotein levels in human immunodeficiency virus-infected subjects on antiretroviral regimens. 2002 BOFFITO M; SCIOLE K; RAITERI R; BONORA S; HOGGARD PG; BACK DJ; G. DI PERRI
Alzheimer Dementia in People Living With HIV 2021 Calcagno, Andrea; Celani, Luigi; Trunfio, Mattia; Orofino, Giancarlo; Imperiale, Daniele; Atzori, Cristiana; Arena, Vincenzo; d'Ettorre, Gabriella; Guaraldi, Giovanni; Gisslen, Magnus; Di Perri, Giovanni
An UPLC MS/MS method coupled with automated on-line solid phase extraction for quantification of tacrolimus in PBMC samples 2014 Pensi D; De Nicolò A; Pinon M; Calvo PL; Di Perri G; D'Avolio A